Increased Hospitalizations Involving Fungal Infections during COVID-19 Pandemic, United States, January 2020-December 2021.

COVID-19 Pneumocystis SARS SARS-CoV-2 United States aspergillosis blastomycosis candidiasis coccidioidomycosis coronavirus coronavirus disease cryptococcosis fungi histoplasmosis hospitalizations international classification of diseases invasive fungal infections mucormycosis mycoses pneumonia respiratory infections severe acute respiratory syndrome coronavirus 2 viruses zoonoses

Journal

Emerging infectious diseases
ISSN: 1080-6059
Titre abrégé: Emerg Infect Dis
Pays: United States
ID NLM: 9508155

Informations de publication

Date de publication:
07 2023
Historique:
medline: 26 6 2023
pubmed: 22 6 2023
entrez: 22 6 2023
Statut: ppublish

Résumé

Hospitalizations involving fungal infections increased 8.5% each year in the United States during 2019-2021. During 2020-2021, patients hospitalized with COVID-19-associated fungal infections had higher (48.5%) in-hospital mortality rates than those with non-COVID-19-associated fungal infections (12.3%). Improved fungal disease surveillance is needed, particularly during respiratory virus pandemics.

Identifiants

pubmed: 37347805
doi: 10.3201/eid2907.221771
pmc: PMC10310397
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1433-1437

Références

Clin Infect Dis. 2012 Feb;54 Suppl 1:S16-22
pubmed: 22247441
Emerg Infect Dis. 2022 Oct;28(10):
pubmed: 36149028
J Fungi (Basel). 2022 Apr 12;8(4):
pubmed: 35448621
MMWR Morb Mortal Wkly Rep. 2020 Aug 21;69(33):1133-1138
pubmed: 32817604
Open Forum Infect Dis. 2023 Feb 24;10(3):ofad100
pubmed: 36968955
Open Forum Infect Dis. 2022 Jan 10;9(1):ofab593
pubmed: 35036461
Open Forum Infect Dis. 2022 Sep 07;9(9):ofac461
pubmed: 36196298
Open Forum Infect Dis. 2021 Nov 16;8(12):ofab510
pubmed: 34877364
Clin Infect Dis. 2022 Apr 28;74(8):1489-1492
pubmed: 34351392
Open Forum Infect Dis. 2022 Apr 21;9(7):ofac215
pubmed: 35794945
JAMA. 2020 Jun 23;323(24):2466-2467
pubmed: 32391864
Clin Infect Dis. 2023 Feb 8;76(3):e255-e262
pubmed: 35717660
JAMA. 2020 Dec 22;324(24):2553-2554
pubmed: 33351033
Lancet Microbe. 2022 Jul;3(7):e543-e552
pubmed: 35098179

Auteurs

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH